Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now TSXV - Delayed Quote • CAD NeuPath Health Inc. (NPTH.V) Follow Add holdings 0.1950 +0.0050 +(2.63%) At close: April 25 at 3:34:16 PM EDT Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for NPTH.V 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: NPTH.V View More All News Press Releases SEC Filings NEUPATH APPOINTS STEPHEN LEMIEUX AS PRESIDENT TO DRIVE NEXT PHASE OF STRATEGIC GROWTH NeuPath Health Full Year 2024 Earnings: CA$0.013 loss per share (vs CA$0.002 loss in FY 2023) NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2024 RESULTS NEUPATH HEALTH SECURES NEW CREDIT FACILITIES TO DRIVE GROWTH AND TO REFINANCE EXISTING DEBT NEUPATH HEALTH THE FIRST NORTH AMERICAN PROVIDER OF ARTHROSAMID®, A REVOLUTIONARY INJECTION FOR KNEE OSTEOARTHRITIS NEUPATH HEALTH ANNOUNCES ISSUANCE OF STOCK OPTIONS AND RESTRICTED SHARE UNITS NEUPATH HEALTH ANNOUNCES APPROVAL OF NORMAL COURSE ISSUER BID NeuPath Health Third Quarter 2024 Earnings: CA$0.007 loss per share (vs CA$0.007 profit in 3Q 2023) NEUPATH HEALTH REPORTS THIRD QUARTER 2024 RESULTS NEUPATH HEALTH TO BE FEATURED ON RADIUS RESEARCH’S PITCH, DEEP DIVE AND Q&A WEBINAR NeuPath Health Second Quarter 2024 Earnings: EPS: CA$0.005 (vs CA$0.001 in 2Q 2023) Related Tickers NVLPF Nova Leap Health Corp. 0.1800 0.00% AMS American Shared Hospital Services 2.7500 -2.48% DR.TO Medical Facilities Corporation 15.00 0.00% EXE.TO Extendicare Inc. 13.35 +0.45% WELL.TO WELL Health Technologies Corp. 4.0100 +1.26%